You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Malaria in Pregnancy, Prevention (Green-top Guideline No. 54A)

Summary: The aim of this guideline is to provide clinicians with evidence-based, up-to-date information about the prevention of malaria in pregnancy in situations that are likely to be encountered in UK medical facilities (that is, UK-based residents visiting malaria endemic areas). These guidelines are not necessarily appropriate for those residing in endemic areas.

This guideline covers malaria prevention travel recommendations in:

  • Women planning a pregnancy
  • Those already pregnant or breast feeding

Please note that drug recommendations for malaria prophylaxis can change owing to resistance. Up-to-date information on drugs can be obtained using online resources as described in this guideline.

Information about the diagnosis and treatment of malaria in pregnancy can be found in Green-top Guideline No. 54b: Diagnosis and treatment of malaria in pregnancy.

COVID disclaimer: This guideline was developed as part of the regular programme of Green-top Guidelines, as outlined in our document Developing a Green-top Guideline: Guidance for developers (PDF), and prior to the emergence of COVID-19.

Version history: This is the first edition of this guideline.

The Advisory committee on malaria prevention have agreed to take over and update this guideline. This version will remain valid until the publication of the new guidance.

Developer declaration of interests: Available on request.



This page was last reviewed 28 April 2010.